147 related articles for article (PubMed ID: 16547154)
1. Genomic and expression analysis of the 3q25-q26 amplification unit reveals TLOC1/SEC62 as a probable target gene in prostate cancer.
Jung V; Kindich R; Kamradt J; Jung M; Müller M; Schulz WA; Engers R; Unteregger G; Stöckle M; Zimmermann R; Wullich B
Mol Cancer Res; 2006 Mar; 4(3):169-76. PubMed ID: 16547154
[TBL] [Abstract][Full Text] [Related]
2. Sec62 bridges the gap from 3q amplification to molecular cell biology in non-small cell lung cancer.
Linxweiler M; Linxweiler J; Barth M; Benedix J; Jung V; Kim YJ; Bohle RM; Zimmermann R; Greiner M
Am J Pathol; 2012 Feb; 180(2):473-83. PubMed ID: 22197383
[TBL] [Abstract][Full Text] [Related]
3. RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer.
Porkka KP; Tammela TL; Vessella RL; Visakorpi T
Genes Chromosomes Cancer; 2004 Jan; 39(1):1-10. PubMed ID: 14603436
[TBL] [Abstract][Full Text] [Related]
4. DNA sequence amplification in human prostate cancer identified by chromosome microdissection: potential prognostic implications.
Van Den Berg C; Guan XY; Von Hoff D; Jenkins R; Bittner ; Griffin C; Kallioniemi O; Visakorpi ; McGill ; Herath J
Clin Cancer Res; 1995 Jan; 1(1):11-8. PubMed ID: 9815882
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 3p12.3-p14.2 and 3q26.2-q26.32 are genomic markers for prognosis of advanced nasopharyngeal carcinoma.
Sheu JJ; Lee CH; Ko JY; Tsao GS; Wu CC; Fang CY; Tsai FJ; Hua CH; Chen CL; Chen JY
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2709-16. PubMed ID: 19815638
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence in situ hybridization analysis of c-myc amplification in stage TNM prostate cancer in Japanese patients.
Sato H; Minei S; Hachiya T; Yoshida T; Takimoto Y
Int J Urol; 2006 Jun; 13(6):761-6. PubMed ID: 16834657
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.
Schlomm T; Kirstein P; Iwers L; Daniel B; Steuber T; Walz J; Chun FH; Haese A; Kollermann J; Graefen M; Huland H; Sauter G; Simon R; Erbersdobler A
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6579-84. PubMed ID: 18006757
[TBL] [Abstract][Full Text] [Related]
8. Identification of CCND3 and BYSL as candidate targets for the 6p21 amplification in diffuse large B-cell lymphoma.
Kasugai Y; Tagawa H; Kameoka Y; Morishima Y; Nakamura S; Seto M
Clin Cancer Res; 2005 Dec; 11(23):8265-72. PubMed ID: 16322284
[TBL] [Abstract][Full Text] [Related]
9. Novel amplification unit at chromosome 3q25-q27 in human prostate cancer.
Sattler HP; Lensch R; Rohde V; Zimmer E; Meese E; Bonkhoff H; Retz M; Zwergel T; Bex A; Stoeckle M; Wullich B
Prostate; 2000 Nov; 45(3):207-15. PubMed ID: 11074522
[TBL] [Abstract][Full Text] [Related]
10. Systematic interrogation of 3q26 identifies TLOC1 and SKIL as cancer drivers.
Hagerstrand D; Tong A; Schumacher SE; Ilic N; Shen RR; Cheung HW; Vazquez F; Shrestha Y; Kim SY; Giacomelli AO; Rosenbluh J; Schinzel AC; Spardy NA; Barbie DA; Mermel CH; Weir BA; Garraway LA; Tamayo P; Mesirov JP; Beroukhim R; Hahn WC
Cancer Discov; 2013 Sep; 3(9):1044-57. PubMed ID: 23764425
[TBL] [Abstract][Full Text] [Related]
11. 3q26 Amplification and polysomy of chromosome 3 in squamous cell lesions of the lung: a fluorescence in situ hybridization study.
Pelosi G; Del Curto B; Trubia M; Nicholson AG; Manzotti M; Veronesi G; Spaggiari L; Maisonneuve P; Pasini F; Terzi A; Iannucci A; Viale G
Clin Cancer Res; 2007 Apr; 13(7):1995-2004. PubMed ID: 17404079
[TBL] [Abstract][Full Text] [Related]
12. TERC identified as a probable target within the 3q26 amplicon that is detected frequently in non-small cell lung cancers.
Yokoi S; Yasui K; Iizasa T; Imoto I; Fujisawa T; Inazawa J
Clin Cancer Res; 2003 Oct; 9(13):4705-13. PubMed ID: 14581340
[TBL] [Abstract][Full Text] [Related]
13. Mapping the amplification of EIF3S3 in breast and prostate cancer.
Nupponen NN; Isola J; Visakorpi T
Genes Chromosomes Cancer; 2000 Jun; 28(2):203-10. PubMed ID: 10825005
[TBL] [Abstract][Full Text] [Related]
14. Identification of SEC62 as a potential marker for 3q amplification and cellular migration in dysplastic cervical lesions.
Linxweiler M; Bochen F; Schick B; Wemmert S; Al Kadah B; Greiner M; Hasenfus A; Bohle RM; Juhasz-Böss I; Solomayer EF; Takacs ZF
BMC Cancer; 2016 Aug; 16(1):676. PubMed ID: 27553742
[TBL] [Abstract][Full Text] [Related]
15. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
[TBL] [Abstract][Full Text] [Related]
16. BCL2L2 is a probable target for novel 14q11.2 amplification detected in a non-small cell lung cancer cell line.
Kawasaki T; Yokoi S; Tsuda H; Izumi H; Kozaki K; Aida S; Ozeki Y; Yoshizawa Y; Imoto I; Inazawa J
Cancer Sci; 2007 Jul; 98(7):1070-7. PubMed ID: 17459056
[TBL] [Abstract][Full Text] [Related]
17. Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer.
Savinainen KJ; Linja MJ; Saramäki OR; Tammela TL; Chang GT; Brinkmann AO; Visakorpi T
Br J Cancer; 2004 Mar; 90(5):1041-6. PubMed ID: 14997205
[TBL] [Abstract][Full Text] [Related]
18. Overexpression and gene amplification of BAG-1L in hormone-refractory prostate cancer.
Mäki HE; Saramäki OR; Shatkina L; Martikainen PM; Tammela TL; van Weerden WM; Vessella RL; Cato AC; Visakorpi T
J Pathol; 2007 Aug; 212(4):395-401. PubMed ID: 17503439
[TBL] [Abstract][Full Text] [Related]
19. Scanning copy number and gene expression on the 18q21-qter chromosomal region by the systematic multiplex PCR and reverse transcription-PCR methods.
Yamamoto F; Yamamoto M
Electrophoresis; 2007 Jun; 28(12):1882-95. PubMed ID: 17523142
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein 7 is widely overexpressed in primary breast cancer.
Alarmo EL; Rauta J; Kauraniemi P; Karhu R; Kuukasjärvi T; Kallioniemi A
Genes Chromosomes Cancer; 2006 Apr; 45(4):411-9. PubMed ID: 16419056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]